We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+14.45%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$3.02B
AUM Growth
-$134M
(-4.3%)
Cap. Flow
-$450M
Cap. Flow
% of AUM
-14.91%
Top 10 Holdings %
Top 10 Hldgs %
49.86%
Holding
60
New
11
Increased
11
Reduced
17
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$131M |
| 2 |
Cigna
CI
|
+$111M |
| 3 |
AGN
Allergan plc
AGN
|
+$101M |
| 4 |
CVS Health
CVS
|
+$91.5M |
| 5 |
Medtronic
MDT
|
+$87.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$133M |
| 2 |
Merck
MRK
|
+$119M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$114M |
| 4 |
Elevance Health
ELV
|
+$96.2M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$85.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 88.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Myriad Genetics
MYGN
$303M
| – | – |
-58,335
| Closed | -$2.18M |
|
52
Qiagen
QGEN
$8.73B
| – | – |
-1,360,735
| Closed | -$52.2M |
|
53
PUT
Invesco QQQ Trust
QQQ
$485B
| – | – |
-205,000
| Closed | -$35.2M |
|
54
Tenet Healthcare
THC
$20.4B
| – | – |
-157,550
| Closed | -$5.29M |
|
|
55
Thermo Fisher Scientific
TMO
$209B
| – | – |
-550,000
| Closed | -$114M |
|
56
Universal Health Services
UHS
$10.2B
| – | – |
-437,620
| Closed | -$48.8M |
|
57
Viatris
VTRS
$20.6B
| – | – |
-161,930
| Closed | -$5.85M |
|
|
PDCO
58
PUT
DELISTED
Patterson Companies, Inc.
PDCO
| – | – |
-200,000
| Closed | -$4.53M |
|
|
ALXN
59
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-486,300
| Closed | -$60.4M |
|
|
CELG
60
CALL
DELISTED
Celgene Corp
CELG
| – | – |
-300,000
| Closed | -$23.8M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q3 2018 Portfolio in Review
As of Q3 2018, HealthCor Management held 60 positions worth $3.02B, down 4.3% from $3.15B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
HealthCor Management withdrew a net $450M in Q3 2018, closing 19 positions and reducing 17 holdings. Its most notable exit was Baxter International, an estimated $133M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 88% a quarter earlier.
Against the trend, HealthCor Management opened a new position in Cigna worth $125M.
- HealthCor Management's largest Q3 2018 buy was Cigna: 600,000 shares worth $125M.
- HealthCor Management added most to Stryker in Q3 2018, an estimated $131M increase.
- HealthCor Management's biggest Q3 2018 reduction was Merck, cutting an estimated $119M.
- HealthCor Management fully exited Baxter International in Q3 2018, selling an estimated $133M.
- HealthCor Management's ten largest holdings make up 50% of its $3.02B portfolio in Q3 2018.
- HealthCor Management opened 11 new positions and closed 19 in Q3 2018.
- HealthCor Management's portfolio value fell 4.3% quarter-over-quarter to $3.02B.
Based on HealthCor Management's 13F filing for Q3 2018, filed 15 Nov 2018.